New pharmaceutical drugs are primarily developed by biopharmaceutical and pharmaceutical companies, ranging from small-scale clinical-stage biotechnology startups to massive multinational enterprises. These corporate entities work in close collaboration with academic research institutions, clinical research organizations (CROs), and specialized hospital networks, guided stringently by regulatory bodies such as the U.S. Food and Drug Administration to ensure safety and therapeutic efficacy during human clinical trials.